Water-Soluble <i>closo</i>-Docecaborate-Containing Pteroyl Derivatives Targeting Folate Receptor-Positive Tumors for Boron Neutron Capture Therapy

Water-soluble pteroyl-<i>closo</i>-dodecaborate conjugates (PBCs 1–4), were developed as folate receptor (FRα) targeting boron carriers for boron neutron capture therapy (BNCT). PBCs 1–4 had adequately low cytotoxicity with IC<sub>50</sub> values in the range of 1~3 mM toward...

Full description

Bibliographic Details
Main Authors: Fumiko Nakagawa, Hidehisa Kawashima, Taiki Morita, Hiroyuki Nakamura
Format: Article
Language:English
Published: MDPI AG 2020-07-01
Series:Cells
Subjects:
Online Access:https://www.mdpi.com/2073-4409/9/7/1615

Similar Items